A novel cell-surface protein CSP82 on bone marrow stem cells and a cytosolic phosphoprotein DP58 (ankyrinRD 34B) are involved in promyeloid progenitor induction

被引:3
作者
Al-Shaibi, Nisreen [1 ]
Ghosh, Swapan K. [1 ]
机构
[1] Indiana State Univ, Dept Life Sci, Terre Haute, IN 47809 USA
关键词
Receptor lactoferrin CSP82; Bone marrow differentiation; Common myeloid progenitor (CMP); Dendritic cells; DP58; phosphoprotein; AnkyrinRD; 34B; PERIPHERAL LYMPHOID ORGANS; DENDRITIC CELLS; IDENTIFICATION; PRECURSORS; EXPRESSION; DIFFERENTIATION; LACTOFERRIN; ESTROGEN; VACCINES; LINEAGE;
D O I
10.1016/j.cellimm.2009.05.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The molecular events associated with the development of common myeloid progenitor (CMP) remain largely unknown. This study reports that a novel glycosylphosphatidylinositol (GPI)-anchored lactoferrin CSP82 on uninitiated mouse bone marrow cells (BMC) may be involved in inducing pro-DC from CMP. By peptide mass fingerprinting, CSP82 has been identified as the mouse lactoferrin precursor, but unlike the latter, it occurs as a GPI-linked cell-surface protein. The GPI-linkage was demonstrated on BMC-derived immunoprecipitates and by other techniques. Furthermore, BMC and hematopoietic stem EM cells following incubation with either CSP82 peptide antibody or purified Reagent A yielded CMP-like progenitors (BM4 cells). These progenitors expressed a previously reported cytosolic phosphoprotein DP58 (AnkRD 34B protein). Continued cultivation of BMC in media containing only anti-CSP82 antibody led to DC-like cells, that bore phenotypic and endocytic resemblance with those obtained using GM-CSF. The results suggest that a receptor lactoferrin on BMC may be an important non-cytokine mechanism for early promyeloid progenitor differentiation. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:172 / 180
页数:9
相关论文
共 41 条
[41]   Dendritic cell biology and cancer therapy [J].
Whiteside, TL ;
Odoux, C .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (03) :240-248